Related references
Note: Only part of the references are listed.A pilot trial of neoantigen DNA vaccine in combination with nivolumab/ipilimumab and prostvac in metastatic hormone-sensitive prostate cancer (mHSPC).
Dhruv Bansal et al.
JOURNAL OF CLINICAL ONCOLOGY (2021)
Personalized neoantigen pulsed dendritic cell vaccine for advanced lung cancer
Zhenyu Ding et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)
A Phase Ib Trial of Personalized Neoantigen Therapy Plus Anti-PD-1 in Patients with Advanced Melanoma, Non-small Cell Lung Cancer, or Bladder Cancer
Patrick A. Ott et al.
CELL (2020)
NeoPredPipe: high-throughput neoantigen prediction and recognition potential pipeline
Ryan O. Schenck et al.
BMC BIOINFORMATICS (2019)
Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trial
Derin B. Keskin et al.
NATURE (2019)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Case report: Long-term survival of a pancreatic cancer patient immunized with an SVN-2B peptide vaccine
Hiroaki Shima et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2018)
Phase II clinical trial of peptide cocktail therapy for patients with advanced pancreatic cancer: VENUS-PC study
Nobuaki Suzuki et al.
CANCER SCIENCE (2017)
Designer vaccine nanodiscs for personalized cancer immunotherapy
Rui Kuai et al.
NATURE MATERIALS (2017)
Overall Survival Prediction and Usefulness of Second-Line Chemotherapy in Advanced Pancreatic Adenocarcinoma
Angelique Vienot et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2017)
Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer
Ugur Sahin et al.
NATURE (2017)
Identification of unique neoantigen qualities in long-term survivors of pancreatic cancer
Vinod P. Balachandran et al.
NATURE (2017)
An immunogenic personal neoantigen vaccine for patients with melanoma
Patrick A. Ott et al.
NATURE (2017)
Overall Survival Prediction and Usefulness of Second-Line Chemotherapy in Advanced Pancreatic Adenocarcinoma
Angelique Vienot et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2017)
TIminer: NGS data mining pipeline for cancer immunology and immunotherapy
Elias Tappeiner et al.
BIOINFORMATICS (2017)
CloudNeo: a cloud pipeline for identifying patient-specific tumor neoantigens
Preeti Bais et al.
BIOINFORMATICS (2017)
A phase Ib study of pembrolizumab plus chemotherapy in patients with advanced cancer (PembroPlus)
Glen J. Weiss et al.
BRITISH JOURNAL OF CANCER (2017)
A phase I dose escalation trial of tremelimumab (CP-675,206) in combination with gemcitabine in chemotherapy-naive patients with metastatic pancreatic cancer
M. Aglietta et al.
ANNALS OF ONCOLOGY (2014)
PRADA: pipeline for RNA sequencing data analysis
Wandaliz Torres-Garcia et al.
BIOINFORMATICS (2014)
Outcomes in Operative Management of Pancreatic Cancer
Lindsay A. Bliss et al.
JOURNAL OF SURGICAL ONCOLOGY (2014)
The immunological and clinical effects of mutated ras peptide vaccine in combination with IL-2, GM-CSF, or both in patients with solid tumors
Osama E. Rahma et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2014)
Gemcitabine and capecitabine with or without telomerase peptide vaccine GV1001 in patients with locally advanced or metastatic pancreatic cancer (TeloVac): an open-label, randomised, phase 3 trial
Gary Middleton et al.
LANCET ONCOLOGY (2014)
Predicting immunogenic tumour mutations by combining mass spectrometry and exome sequencing
Mahesh Yadav et al.
NATURE (2014)
Neoantigen in esophageal squamous cell carcinoma for dendritic cell-based cancer vaccine development
Mohammad Mahdi Forghanifard et al.
MEDICAL ONCOLOGY (2014)
Pancreatic Adenocarcinoma
NEW ENGLAND JOURNAL OF MEDICINE (2014)
IMA901: A multi-peptide cancer vaccine for treatment of renal cell cancer
Alexandra Kirner et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2014)
Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
Daniel D. Von Hoff et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Long-term follow-up of patients with resected pancreatic cancer following vaccination against mutant K-ras
Synne Weden et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
Thierry Conroy et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Central memory and effector memory T cell subsets: Function, generation, and maintenance
F Sallusto et al.
ANNUAL REVIEW OF IMMUNOLOGY (2004)
Intradermal ras peptide vaccination with granulocyte-macrophage colony-stimulating factor as adjuvant:: Clinical and immunological responses in patients with pancreatic adenocarcinoma
MK Gjertsen et al.
INTERNATIONAL JOURNAL OF CANCER (2001)
Share Paper
